Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study.
Victorien L M N SoomersOlga HussonIngrid M E DesarMichiel Adreanus van de SandeJacco J de HaanCornelis VerhoefIngeborg J H VriensWinan J van HoudtLonneke van de Poll-FranseWinette T A van der GraafPublished in: Cancer (2020)
The patient and diagnostic interval lengths were prolonged in a substantial percentage of this sarcoma survivorship population. Factors found to be associated with the length of the patient interval or the diagnostic interval differed. Creating awareness among (especially young) patients to consult a physician and awareness among physicians to consider a sarcoma diagnosis will contribute to optimization of the total interval.